Bank of New York Mellon Corp - BIOTIME INC ownership

BIOTIME INC's ticker is BTX and the CUSIP is 09066L105. A total of 107 filers reported holding BIOTIME INC in Q2 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of BIOTIME INC
ValueSharesWeighting
Q2 2019$449,000
-27.1%
408,904
-13.1%
0.00%
Q1 2019$616,000
+65.1%
470,278
+15.0%
0.00%
Q4 2018$373,000
-79.2%
408,881
-46.5%
0.00%
Q3 2018$1,797,000
+17.1%
764,753
+2.7%
0.00%
Q2 2018$1,534,000
-19.8%
744,554
+4.7%
0.00%
-100.0%
Q1 2018$1,913,000
+35.1%
711,204
+8.0%
0.00%
Q4 2017$1,416,000
+8.1%
658,373
+42.8%
0.00%
Q3 2017$1,310,000
-12.4%
461,000
-2.9%
0.00%
Q2 2017$1,496,000
-2.5%
474,858
+6.7%
0.00%
Q1 2017$1,535,000
+12.2%
445,031
+17.5%
0.00%
Q4 2016$1,368,000
+36.9%
378,836
+47.8%
0.00%
Q3 2016$999,000
+59.1%
256,363
+6.5%
0.00%
Q2 2016$628,000
+4.5%
240,697
+14.9%
0.00%
Q1 2016$601,000
-32.2%
209,519
-3.1%
0.00%
Q4 2015$887,000
+47.1%
216,257
+7.6%
0.00%
Q3 2015$603,000
-30.8%
200,890
-16.2%
0.00%
Q2 2015$871,000
-13.7%
239,808
+18.0%
0.00%
Q1 2015$1,009,000
+26.1%
203,169
-5.3%
0.00%
Q4 2014$800,000
+38.2%
214,502
+16.4%
0.00%
Q3 2014$579,000
-48.0%
184,275
-49.6%
0.00%
Q2 2014$1,114,000
+105.2%
365,292
+121.2%
0.00%
Q1 2014$543,000
-9.5%
165,138
-1.0%
0.00%
Q4 2013$600,000
-50.8%
166,738
-48.1%
0.00%
Q3 2013$1,220,000
+91.2%
321,028
+99.2%
0.00%
Q2 2013$638,000161,1600.00%
Other shareholders
BIOTIME INC shareholders Q2 2019
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 29,971,561$64,439,0008.98%
Manatuck Hill Partners, LLC 351,822$756,0000.39%
DAFNA Capital Management LLC 275,000$591,0000.32%
Prescott General Partners LLC 1,851,851$3,981,0000.18%
CORRADO ADVISORS, LLC 74,875$161,0000.09%
Destination Wealth Management 526,245$1,131,0000.07%
Artal Group S.A. 1,557,050$3,348,0000.05%
Family Management Corp 32,540$70,0000.05%
Granite Point Capital Management, L.P. 229,550$494,0000.05%
IndexIQ Advisors LLC 408,310$878,0000.03%
View complete list of BIOTIME INC shareholders